11 Mar 2024
// DRUG STORE NEWS
26 Feb 2024
// PR NEWSWIRE
05 Dec 2022
// PR NEWSWIRE
Latest Content by PharmaCompass
01 1Deferasirox
02 1Formoterol Fumarate
03 1Lacosamide
04 1Oxcarbazepine
05 1Vigabatrin
01 1Extended Release Capsule
02 1Inhalation Solution
03 1Oral Granule
04 1Oral Solution
05 1Oral Suspension
01 120MCG/2ML
02 1300MG/5ML
03 1360MG
04 1500MG
05 1Blank
01 5U.S.A
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Inhalation Solution
Brand Name :
Dosage Strength : 20MCG/2ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Oral Suspension
Brand Name :
Dosage Strength : 300MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Extended Release Capsule
Brand Name : Motpoly XR
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Oral Solution
Brand Name : Vigadrone
Dosage Strength : 500MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
Regulatory Info :
Registration Country : U.S.A
Dosage Form : Oral Granule
Brand Name :
Dosage Strength : 360MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : U.S.A
LOOKING FOR A SUPPLIER?